Low-Dose Fractionated Radiotherapy Combined with Neoadjuvant Chemotherapy for T3-4 Nasopharyngeal Carcinoma Patients: The Preliminary Results of a Phase II Randomized Controlled Trial.

M Feng, Y Tang,M Fan,L Li, S Wang, Q Yin, H Ai,S Zhao, Y Yin, D Liu, Y Ren,J Li, F Li, J Lang

International journal of radiation oncology, biology, physics（2023）

引用 0|浏览2

暂无评分

摘要

LDFRT combined with NACT could obviously improve the median volume reduction rate and ORR of primary tumor for T3-4 NPC patients, and the toxicity was similar and tolerable. This novel treatment could be a promising strategy to improve treatment response and needed to be confirmed further.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要